Jacqueline M. Fabius

QB3 — United States

Medicine · Health Sciences

12h-index8.3kcitations23works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(14), vaccines and immunoinformatics approaches(6), Computational Drug Discovery Methods(5), interferon and immune responses(5), Mosquito-borne diseases and control(3)

Publications23 total

Paracrine Signals from HIV-1 Infected Immune Cells Reprogram Cervical Cancer Pathways
2025· 2 citedOpen Access
Malaria exposure remodels the plasma proteome of Ghanaian children
BMC Infectious Diseases·2025Open Access
Recovering from the stress of the COVID-19 pandemic
Molecular Cell·2024· 1 citedOpen Access
Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis
Cell Host & Microbe·2023· 74 citedOpen Access
SARS-CoV-2 variants evolve convergent strategies to remodel the host response
Cell·2023· 109 citedOpen Access
Contents list
Molecular Omics·2023Open Access
Lessons learned for pandemic preparedness: A collaborative network is imperative
Cell Host & Microbe·2023· 2 citedOpen Access
Network modeling suggests HIV infection phenocopies PI3K-AKT pathway mutations to enhance HPV-associated cervical cancer
Molecular Omics·2023· 9 citedOpen Access
SARS-CoV-2 Variants Evolve Convergent Strategies to Remodel the Host Response
SSRN Electronic Journal·2023· 12 citedOpen Access
Global landscape of the host response to SARS-CoV-2 variants reveals viral evolutionary trajectories
2022· 13 citedOpen Access
Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis
2022· 24 citedOpen Access
Workshop-based learning and networking: a scalable model for research capacity strengthening in low- and middle-income countries
Global Health Action·2022· 3 citedOpen Access
Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2
Nature·2022· 12 citedOpen Access
Evolution of enhanced innate immune evasion by SARS-CoV-2
Nature·2021· 392 citedOpen Access
Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant
2021· 106 citedOpen Access
Creating collaboration by breaking down scientific barriers
Cell·2021· 9 citedOpen Access
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
Science·2021· 357 citedOpen Access
Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variant
2021· 42 citedOpen Access
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
Science·2020· 795 citedOpen Access
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Cell·2020· 1.1k citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Nevan J. Krogan(19), Mehdi Bouhaddou(18), Danielle L. Swaney(16), Margaret Soucheray(14), Kirsten Obernier(13), Benjamin J. Polacco(13), Jyoti Batra(12), Adolfo Garcı́a-Sastre(12), Kris M. White(11), Lorena Zuliani‐Alvarez(11), Alicia Richards(10), Manon Eckhardt(10), Lisa Miorin(10), Manisha R. Ummadi(10), Ajda Rojc(9), Gwendolyn Μ. Jang(8), Jiewei Xu(8), Ruth Hüttenhain(8), Danish Memon(8), Joseph Hiatt(8)